VENLAFAXINE HYDROCHLORIDE
- Product NDC
- 61919-920
- 11-digit product format
- 619190920
- Labeler code
- 61919
- Product ID
- 61919-920_b6cc4b45-4847-4334-9ce9-81fffcb96dbc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- VENLAFAXINE HYDROCHLORIDE
- Dosage form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Labeler
- DIRECT RX
- Application
- NDA020699
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2015-01-01
- Marketing end
- 0000-00-00
- Substance
- VENLAFAXINE HYDROCHLORIDE
- Active strength
- 75 mg/1
- Pharmacologic classes
- Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61919-920-30 | VENLAFAXINE HYDROCHLORIDE | 30 in 1 BOTTLE | CAPSULE, DELAYED RELEASE | 30 | | 3 |
| 61919-920-90 | VENLAFAXINE HYDROCHLORIDE | 90 in 1 BOTTLE | CAPSULE, DELAYED RELEASE | 90 | | 3 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| VENLAFAXINE HYDROCHLORIDE | ACTIVE INGREDIENT | 7D7RX5A8MO | VENLAFAXINE HYDROCHLORIDE CAPSULE, DELAYED RELEASE [DIRECT RX] | 3 | |
| VENLAFAXINE | ACTIVE MOIETY | GRZ5RCB1QG | VENLAFAXINE HYDROCHLORIDE CAPSULE, DELAYED RELEASE [DIRECT RX] | 3 | |
| ETHYLCELLULOSE (100 MPA.S) | INACTIVE INGREDIENT | 47MLB0F1MV | VENLAFAXINE HYDROCHLORIDE CAPSULE, DELAYED RELEASE [DIRECT RX] | 3 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | VENLAFAXINE HYDROCHLORIDE CAPSULE, DELAYED RELEASE [DIRECT RX] | 3 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | VENLAFAXINE HYDROCHLORIDE CAPSULE, DELAYED RELEASE [DIRECT RX] | 3 | |
| HYPROMELLOSE 2910 (6 MPA.S) | INACTIVE INGREDIENT | 0WZ8WG20P6 | VENLAFAXINE HYDROCHLORIDE CAPSULE, DELAYED RELEASE [DIRECT RX] | 3 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | VENLAFAXINE HYDROCHLORIDE CAPSULE, DELAYED RELEASE [DIRECT RX] | 3 | |
| POWDERED CELLULOSE | INACTIVE INGREDIENT | SMD1X3XO9M | VENLAFAXINE HYDROCHLORIDE CAPSULE, DELAYED RELEASE [DIRECT RX] | 3 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | VENLAFAXINE HYDROCHLORIDE CAPSULE, DELAYED RELEASE [DIRECT RX] | 3 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61919-920 | VENLAFAXINE HYDROCHLORIDE CAPSULE, DELAYED RELEASE [DIRECT RX] | 3 | Legacy NDC, 2 package rows | 20150811_2829937a-d59b-4abb-8873-0970cf4d38a1.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 61919-920-30 | 61919092030 | 30 in 1 BOTTLE | Historical |
| 61919-920-90 | 61919092090 | 90 in 1 BOTTLE | Historical |